About one-third of women with commercial insurance underwent genetic testing for ovarian cancer between 2008 and 2018 despite unequivocal recommendations for universal testing, according to research in JAMA Network Open.
“Our study shows that we desperately need to increase genetic testing in women with ovarian cancer,” Alexi A. Wright, MD, MPH, associate professor at Harvard Medical School and director of gynecologic oncology outcomes research at Dana-Farber Cancer Institute, told Healio. “Every woman with ovarian cancer should have access to genetic testing because the